System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Retracted Publication Epublish 8 citations

PubMed: 34812265 DOI: 10.1155/2021/7394699

Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia.

Evid Based Complement Alternat Med 2021:7394699

Authors: Xiao Zhong, Qin Ao, Fei Xing

Affiliations

  • Psychiatry Department, Jiangxi Province Honorary Military Rehabilitation Hospital (Jiangxi Kangning Hospital), Yuhushan Avenue, Xinjian District, Nanchang 330103, Jiangxi Province, China.
  • Department of Clinical Laboratory, The Second People's Hospital of Huai'an, No. 62, Huaihai South Road, Huai'an City 223001, Jiangsu Province, China.

Abstract

OBJECTIVE

It has been reported that the prevalence of metabolic syndrome (MS) in multiepisode patients with schizophrenia is 35.3%, which is 2- to 4-fold higher than in the general population. The study is designed to compare the glycolipid metabolism in patients with first-episode schizophrenia (FES) with sex- and age-matched healthy controls to investigate changes in serum levels of homocysteine (Hcy), macrophage migration inhibitory factor (MIF), and high-sensitive C-reactive protein (hs-CRP) and their relationships with the glycolipid metabolism in patients with FES.

METHODS

His case-control study included 88 patients diagnosed with FES and 88 sex- and age-matched healthy controls. Patient psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS), Young Mania Rating Scale (YMRS), and 17-item Hamilton Rating Scale for Depression (HAMD-17). Patients with FES were classified into MS and non-MS groups.

RESULTS

There were significant differences in the education level, body mass index (BMI), and waist circumference between the patients with FES and healthy controls (all > 0.05). The patients with FES had higher levels of FPG and blood glucose at the oral glucose tolerance test (OGTT) (2 h glucose) concomitant with higher proportion of impaired glucose tolerance (IGT) and homeostasis model assessment of insulin resistance (HOMA2-IR) than healthy controls (all < 0.001). It was revealed that the patients with FES showed higher serum levels of Hcy, MIF, and hs-CRP than healthy controls (all < 0.001). The serum level of Hcy shared positive correlations with the score of PANSS totals ( = 0.551) and the negative syndrome of the PANSS scale ( = 0.494). The serum levels of MIF and hs-CRP was only positively correlated with the negative syndrome of the PANSS scale ( = 0.320 and  = 0.446). The level of Hcy shared positive correlations with the levels of FPG, 2 h glucose, and HOMA2-IR; the level of MIF was only positively correlated with the level of HOMA2-IR; the level of hs-CRP had a positive correlation with both levels of FPG and 2 h glucose (all < 0.001). The levels of Hcy, MIF, and hs-CRP all shared positive correlations with the TG level and negative correlations with the HDL-C level (all < 0.001). There were remarkable differences between the MS and non-MS groups with regard to BMI, waist circumference, negative subscale of the PANSS scale, FPG, TG, and HDL-C (all < 0.05). Elevated levels of Hcy, MIF, and hs-CRP were detected in the MS group compared to the non-MS group (all < 0.05).

CONCLUSION

These findings suggest that increased concentrations of HCY, MIF, and hs-CRP may contribute to the abnormal glycolipid metabolism in the context of schizophrenia.

MeSH

Serum, C-Reactive Protein, Schizophrenia, Sex, Waist Circumference, Glycolipids

Cited by